Biotech

All Articles

Analysts dig into Avidity's DMD succeed, uncovering distinctions in data

.Avidity Biosciences impressed clients along with stage 1/2 records in Duchenne muscle dystrophy (DM...

Actinogen's cortisol blocker neglects stage 2 anxiety research study

.Actinogen Medical's cortisol blocker has actually overlooked the major endpoint of a phase 2 study ...

Bivictrix chooses going exclusive only technique to take ADC in to medical clinic

.Antibody-drug conjugates (ADCs) have actually been at the center of numerous a billion-dollar biobu...

TPG tops up funds to $580M for expenditures around life scientific researches

.Possession supervisor TPG, which has actually supported biotechs like Sionna Rehabs as well as Sant...

Merck quits period 3 TIGIT trial in lung cancer cells for impossibility

.Merck &amp Co.'s TIGIT course has experienced an additional obstacle. Months after shuttering a per...

After a tough year, Exscientia folds up into Recursion

.After a year specified by pipeline cuts, the variation of its own chief executive officer and disch...

Cullinan, after $25M bargain, return bispecific to Port

.Cullinan Therapy was wowed good enough along with Port BioMed's bispecific immune system reactor th...

A nearer consider Strong Biotech's Fierce 15

.In this full week's episode of "The Top Line," our experts are actually diving into Intense Biotech...

Lilly faces stage 2 failure of tau-targeting med

.The confetti is still flying from Eli Lilly's gathering celebrating the commendation of Alzheimer's...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our summary of notable leadership hirings, firings and r...